The Cost of Delaying Solid-State Screening

Across development programs, solid-state work is often treated as an upfront cost that can be deferred without penalty. However, in reality, greater expense will be incurred by doing this work after clinical commitments, regulatory filings, and IP positions have already narrowed the viable paths forward.

Hence, it is recommended to engage with experts whose experience can anticipate downstream requirements, and work to provide early intervention toward optimizing programs in a phase appropriate way. Additional benefits include the creation of composition of matter patents that can increase longevity and value in the market.